A urine test developed by scientists at the University of Cambridge has moved a step closer to clinical use following new findings revealing it could do more than first thought.
Using ultrasound to stimulate a specific part of the brain could offer a noninvasive therapy that benefits those experiencing chronic pain, a new study has suggested.
IVDR-compliant PCR test supports detection of 11 clinically relevant gastrointestinal pathogens from 1 sample
Glioblastoma is one of the deadliest forms of brain cancer, and despite surgery, radiation, and chemotherapy, the disease almost always returns. Part of the reason is that these tumors are remarkably good at evading the immune system.
A virus many people associate with sick puppies is once again spreading across parts of the U.S., but this outbreak involves a completely different virus that infects humans.
The CE mark was granted based on data from retrospective studies in real-world early cognitive decline population.
Researchers at Rice University, in collaboration with The University of Texas MD Anderson Cancer Center and clinical partners, have reported results from a first-in-human trial evaluating a novel cell-based platform for localized delivery of interleukin-2 (IL-2) in patients with advanced ovarian cancer.
A new way to detect the onset of heart and kidney disease far earlier than previously possible has been discovered by scientists. The breakthrough, published today in Nature Communications, reveals a novel method for identifying damage to the lining of microscopic blood vessels.
Researchers at Rice University and The University of Texas MD Anderson Cancer Center have developed a compact, artificial intelligence-powered imaging device that could transform how clinicians detect cancer. The technology, which aims to bring high-resolution, real-time diagnostics directly to the point of care, was recently described in a paper published in the Proceedings of the National Academy of Sciences.
Now, a team of researchers from Memorial Sloan Kettering Cancer Center (MSK) has developed a new type of CAR T cell therapy that targets a protein found almost exclusively on leukemia cells and not on healthy cells.